Incorporating molecular and functional context into the analysis and prioritization of human variants associated with cancer.
With recent breakthroughs in high-throughput sequencing, identifying deleterious mutations is one of the key challenges for personalized medicine. At the gene and protein level, it has proven difficult to determine the impact of previously unknown variants. A statistical method has been developed to assess the significance of disease mutation clusters on protein domains by incorporating domain functional annotations to assist in the functional characterization of novel variants.
Author(s): Peterson, Thomas A, Nehrt, Nathan L, Park, Dohwan, Kann, Maricel G
DOI: 10.1136/amiajnl-2011-000655